SCHEMBL3575868

SCHEMBL3575868

Cc1cccc(OCC(CS(=O)(=O)Cc2ccccc2)NC(=O)OC(C)(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 3/20 0.47
NPSR1 Q6W5P4 3/20 0.47
KMT2A Q03164 3/20 0.47
JAK2 O60674 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PKM P14618 2/20 0.47
ATM Q13315 2/20 0.43
XBP1 P17861 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 2/20 0.42
TP53 P04637 2/20 0.42
S1PR4 O95977 1/20 0.42
F2 P00734 1/20 0.42
MAPT P10636 1/20 0.42
MEN1 O00255 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3574358 0.82 PPARG (0.53) HPGDLMNAHTTNPSR1KMT2A
SCHEMBL3573224 0.81 ADRB2 (0.47) LMNAKMT2AALDH1A1ATMMEN1
SCHEMBL3573225 0.81 ADRB2 (0.47) LMNAKMT2AALDH1A1ATMMEN1
SCHEMBL3576724 0.79 CCKBR (0.40) HPGDLMNAHTTKMT2AALDH1A1
SCHEMBL3578683 0.79 KMT2A (0.45) HPGDLMNANPSR1KMT2AALDH1A1
SCHEMBL3575439 0.78 SYK (0.66) HPGDLMNAHTTKMT2AATM
SCHEMBL14134838 0.77 PPARA (0.52) HTTSMN1; SMN2PPARAADRB2ADRB1
SCHEMBL30639552 0.75 ATM (0.65) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL6854832 0.74 ATM (0.56) ATMHSD17B10HDAC3HDAC4HDAC1
SCHEMBL6630572 0.74 PPARA (0.57) HPGDLMNAHTTNPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728005-B2 Ether derivative AJINOMOTO CO., INC. (JP) 2010-06-01 US disclosed
US-20060270693-A1 Ether derivative AJINOMOTO CO., INC. (JP) 2006-11-30 US disclosed
EP-1679296-A1 ETHER DERIVATIVE Ajinomoto Co., Inc. (JP) 2006-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270693-A1 Ether derivative UROD, IL5, IL17A HPGD 82/4885LMNA 4055/4885HTT 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.